Wildlife-microbiome interactions and disease: exploring opportunities for disease mitigation across ecological scales

Q3 Pharmacology, Toxicology and Pharmaceutics Drug Discovery Today: Disease Models Pub Date : 2018-06-01 DOI:10.1016/j.ddmod.2019.08.012
Candace L. Williams , Andrés Mauricio Caraballo-Rodríguez , Celeste Allaband , Amir Zarrinpar , Rob Knight , Julia M. Gauglitz
{"title":"Wildlife-microbiome interactions and disease: exploring opportunities for disease mitigation across ecological scales","authors":"Candace L. Williams ,&nbsp;Andrés Mauricio Caraballo-Rodríguez ,&nbsp;Celeste Allaband ,&nbsp;Amir Zarrinpar ,&nbsp;Rob Knight ,&nbsp;Julia M. Gauglitz","doi":"10.1016/j.ddmod.2019.08.012","DOIUrl":null,"url":null,"abstract":"<div><p>Captive wildlife are a unique set of animals, whose diverse host–microbe symbioses are underexplored. Compared to their wild counterparts they are particularly susceptible to a variety of diseases, many of which have explicit or purported links to the microbiome. In this perspective, we will examine how the microbiome influences gastrointestinal disorders, metabolic dysregulation, reproduction, and disease susceptibility in captive wildlife. Investigation of wildlife, and specifically captive wildlife, affords a unique opportunity to gain understanding of the broad diversity of the associated microbiota and learn from nature’s molecular and microbial responses to disease. Studies like these could lead to the discovery of new interventions, ranging from dietary changes to the use of microbes or their natural products as treatment. Intervention strategies can lead to the discovery of medically relevant small molecules and the development of a novel platform for N-of-1 targeted medical investigations.</p></div>","PeriodicalId":39774,"journal":{"name":"Drug Discovery Today: Disease Models","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ddmod.2019.08.012","citationCount":"21","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today: Disease Models","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1740675719300192","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 21

Abstract

Captive wildlife are a unique set of animals, whose diverse host–microbe symbioses are underexplored. Compared to their wild counterparts they are particularly susceptible to a variety of diseases, many of which have explicit or purported links to the microbiome. In this perspective, we will examine how the microbiome influences gastrointestinal disorders, metabolic dysregulation, reproduction, and disease susceptibility in captive wildlife. Investigation of wildlife, and specifically captive wildlife, affords a unique opportunity to gain understanding of the broad diversity of the associated microbiota and learn from nature’s molecular and microbial responses to disease. Studies like these could lead to the discovery of new interventions, ranging from dietary changes to the use of microbes or their natural products as treatment. Intervention strategies can lead to the discovery of medically relevant small molecules and the development of a novel platform for N-of-1 targeted medical investigations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
野生动物-微生物群相互作用与疾病:探索跨生态尺度的疾病缓解机会
圈养野生动物是一组独特的动物,其不同的宿主-微生物共生关系尚未得到充分探索。与它们的野生同类相比,它们特别容易受到各种疾病的影响,其中许多疾病与微生物群有明确的或据称的联系。从这个角度来看,我们将研究微生物组如何影响胃肠道疾病、代谢失调、繁殖和圈养野生动物的疾病易感性。对野生动物,特别是圈养野生动物的调查,提供了一个独特的机会,可以了解相关微生物群的广泛多样性,并了解自然界对疾病的分子和微生物反应。像这样的研究可能会导致发现新的干预措施,从饮食改变到使用微生物或其天然产物作为治疗。干预策略可以导致发现与医学相关的小分子,并为N-of-1靶向医学研究开发新的平台。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Discovery Today: Disease Models
Drug Discovery Today: Disease Models Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
自引率
0.00%
发文量
0
期刊介绍: Drug Discovery Today: Disease Models discusses the non-human experimental models through which inference is drawn regarding the molecular aetiology and pathogenesis of human disease. It provides critical analysis and evaluation of which models can genuinely inform the research community about the direct process of human disease, those which may have value in basic toxicology, and those which are simply designed for effective expression and raw characterisation.
期刊最新文献
Balanced actions of estradiol and progesterone—A new paradigm of women’s reproductive health Women’s reproductive system as balanced estradiol and progesterone actions—A revolutionary, paradigm-shifting concept in women’s health Influence of progestagens on bone health. Bone changes related to ovulatory disturbances and low progesterone levels Hereditary bullous diseases: current and innovative models to study the skin blistering disease epidermolysis bullosa The extent and causes of natural variation in menstrual cycles: Integrating empirically-based models of ovarian cycling into research on women’s health
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1